DEXCOM INC. DL-,001/ US2521311074 /
2024-06-07 8:00:48 AM | Chg. -2.46 | Volume | Bid10:00:00 PM | Ask10:00:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.60EUR | -2.28% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 42.63 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.